Metoprolol Succinate Tablet, Extended Release
Product Images NDC 70518-4407

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70518-4407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Metoprolol succinate 100 mg extended-release tablet label showing quantity of 30 tablets. The label includes the NDC number 70518-4407-00 and repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions and manufacturer (Epic Pharma, LLC) location are also visible.*

FDA Label Image

Picture-1 (Picture 1)

A forest plot chart titled 'Results for Subgroups in MERIT-HF,' showing relative risk and 95% confidence intervals for metoprolol succinate extended release tablets versus placebo. Three outcomes are displayed: total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. Subgroups analyzed include geographic location, NYHA class, ejection fraction, etiology, sex, race, medical history, diabetes status, hypertension history, and heart rate.*

FDA Label Image

Structure (Structure)

Chemical structure of Metoprolol succinate. The diagram shows the molecular arrangement including aromatic ring, hydroxyl group, and succinate moiety with detailed bonds and groups as commonly represented in chemical formulas.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.